We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NKE:NYSENike, Inc. Analysis

Data as of 2026-06-01 - not real-time

$46.23

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Nike (NKE) is trading at $46.23, comfortably above its 20‑day (≈$43.84) and 50‑day (≈$45.71) moving averages but still well below the 200‑day SMA (≈$61.05), signaling a short‑term bounce within a longer‑term bearish backdrop. The MACD histogram is positive and the line sits above the signal, offering a bullish micro‑signal, while the RSI at 57 suggests the stock is not yet overbought. Volume is increasing and the price sits between a clear support at $41.35 and resistance near $47.65, making the next few sessions a test of whether the bullish momentum can break the ceiling.
Fundamentally, Nike’s revenue is essentially flat (≈0.1% growth) and margins are modest (gross 41%, operating 7%). The forward P/E of ~25 and a price‑to‑book of 4.86 indicate a premium valuation, yet the discounted cash‑flow model points to a fair value of only $9.69, implying a deep undervaluation relative to current pricing. The dividend yield is attractive at 3.55% but the payout ratio exceeds 100%, raising sustainability concerns. Analyst consensus remains “Buy” with a mean target of $60.78, reflecting optimism about upside potential despite the high leverage (debt‑to‑equity ~79%).

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Positive MACD histogram indicating near‑term bullish pressure
  • High 30‑day volatility (~27%) increasing price uncertainty
  • Proximity to resistance at $47.65 limiting upside

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • DCF fair value far below market suggesting upside >30%
  • Analyst consensus buy with mean target $60.78
  • Increasing trading volume supporting momentum

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Strong brand moat and global distribution network
  • Flat revenue growth and high leverage raising financial risk
  • Unsustainable dividend payout ratio limiting income appeal

Key Metrics & Analysis

Financial Health

Revenue Growth0.10%
Profit Margin4.84%
P/E Ratio30.4
ROE16.02%
ROA5.20%
Debt/Equity79.33
P/B Ratio4.9
Op. Cash Flow$1.7B
Free Cash Flow$1.3B

Technical Analysis

TrendBearish
RSI57.6
Support$41.35
Resistance$47.65
MA 20$43.84
MA 50$45.71
MA 200$61.05
MACDBullish
VolumeIncreasing
Fear & Greed Index93.18

Valuation

Fair Value$9.69
Target Price$60.78
Upside/Downside31.46%
GradeUndervalued
TypeValue
Dividend Yield3.55%

Risk Assessment

Beta0.97
Volatility26.84%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.